Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00577447 · ClinicalTrials.gov registry record · NA
Docosahexaenoic Acid in the Treatment of Autism
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT00577447: Completed NA study, sponsored by Mayo Clinic.
NCT00577447 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00577447, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to test the hypothesis that dietary supplementation with the omega-3 fatty acid docosahexaenoic acid (DHA) improves the behavior of children with autism.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT docosahexaenoic acid (DHA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2005-10 |
| Est. Completion | 2007-11 |
| Phase | NA |
What the finished NCT00577447 record still lists
NCT00577447 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00577447 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00577447 about?
NCT00577447 is a clinical study titled "Docosahexaenoic Acid in the Treatment of Autism". The purpose of this study is to test the hypothesis that dietary supplementation with the omega-3 fatty acid docosahexaenoic acid (DHA) improves the behavior of children with autism.
What is the current status of trial NCT00577447?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2005-10. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00577447?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), docosahexaenoic acid (DHA) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00577447?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00577447's enrollment target sits among peer trials
48 1381st of 2000 higher than 601 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia